ECL's robust product lineup, innovation-driven growth and strong Q2 results underscore its long-term potential despite macroeconomic headwinds.
Vous n'êtes pas connecté
Maroc - ZACKS.COM - All Stories - 04/12/2025 15:12
SWK pushes toward $2B in cost savings as supply-chain actions, portfolio moves and shareholder returns reshape its long-term outlook.
ECL's robust product lineup, innovation-driven growth and strong Q2 results underscore its long-term potential despite macroeconomic headwinds.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium...
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium...
Procter & Gamble depends on productivity from cost savings to supply-chain efficiencies to protect margins and support EPS as inflation pressures...
MMSI's WRAPSODY reimbursement tailwinds, expanding high-margin portfolio and strong cash flow set up growth into 2026 despite macro and forex...
MMSI's WRAPSODY reimbursement tailwinds, expanding high-margin portfolio and strong cash flow set up growth into 2026 despite macro and forex...
CorMedix's DefenCath drives revenues with strong adoption, but 2026 outlook signals slower growth, raising concerns over long-term adoption.
CorMedix's DefenCath drives revenues with strong adoption, but 2026 outlook signals slower growth, raising concerns over long-term adoption.
Visa's volume-driven growth, cross-border expansion and AI investments support long-term prospects, but rising costs and regulatory risks keep the...